Have a specific question about your LBP project? Click below and let’s get started.
Nature Neuroscience
Andreadou, M;Ingelfinger, F;De Feo, D;Cramer, TLM;Tuzlak, S;Friebel, E;Schreiner, B;Eede, P;Schneeberger, S;Geesdorf, M;Ridder, F;Welsh, CA;Power, L;Kirschenbaum, D;Tyagarajan, SK;Greter, M;Heppner, FL;Mundt, S;Becher, B;
Interleukin-12 (IL-12) is a potent driver of type 1 immunity. Paradoxically, in autoimmune conditions, including of the CNS, IL-12 reduces inflammation. The underlying mechanism behind these opposing properties and the involved cellular players remain elusive. Here we map IL-12 receptor (IL-12R) expression to NK and T cells as well as neurons and oligodendrocytes. Conditionally ablating the IL-12R across these cell types in adult mice and assessing their susceptibility to experimental autoimmune encephalomyelitis revealed that the neuroprotective role of IL-12 is mediated by neuroectoderm-derived cells, specifically neurons, and not immune cells. In human brain tissue from donors with multiple sclerosis, we observe an IL-12R distribution comparable to mice, suggesting similar mechanisms in mice and humans. Combining flow cytometry, bulk and single-nucleus RNA sequencing, we reveal an IL-12-induced neuroprotective tissue adaption preventing early neurodegeneration and sustaining trophic factor release during neuroinflammation, thereby maintaining CNS integrity in mice.